| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |